Guest Editorial
详细信息    查看全文
文摘
Neoadjuvant therapy is increasingly used in the treatment of gastrointestinal malignancies. New molecular target-specific agents also have a role in downstaging hepatic colorectal metastases and metastatic gastrointestinal stromal tumours. Pathologists need to be familiar with post-treatment changes and with tumour regression grading systems. Accurate assessment of specimens is crucial for prognostic purposes and to evaluate therapeutic response. A standardized pathological approach is recommended.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700